KMT2A and leukemia: A survey of histone modifications initially identified H3K79Me2 as a mark associated with MLL-ENL and MLL-AF9 activation of target genes [13], but the first study to directly implicate DOT1L in MLL-FP leukemias was the work of Okada et al. [220].